Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats

• Egile Nagusiak: Abeer M. Alanazi (Egilea), Laila Fadda (Egilea), Ahlam Alhusaini (Egilea), Rehab Ahmad (Egilea), Iman H. Hasan (Egilea), Ayman M. Mahmoud (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2020-02-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Doxorubicin (DOX) is a cytotoxic anthracycline antibiotic and one of the important chemotherapeutic agents for different types of cancers. DOX treatment is associated with adverse effects, particularly cardiac dysfunction. This study examined the cardioprotective effects of carvedilol (CAR) and/or r...